A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents
about
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 15 November 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
A phase II study of omacetaxin ...... lure of hypomethylating agents
@en
A phase II study of omacetaxin ...... lure of hypomethylating agents
@nl
type
label
A phase II study of omacetaxin ...... lure of hypomethylating agents
@en
A phase II study of omacetaxin ...... lure of hypomethylating agents
@nl
prefLabel
A phase II study of omacetaxin ...... lure of hypomethylating agents
@en
A phase II study of omacetaxin ...... lure of hypomethylating agents
@nl
P2093
P50
P356
P1476
A phase II study of omacetaxin ...... lure of hypomethylating agents
@en
P2093
Gabriela Sanchez-Petitto
Graciela M Nogueras-Gonzalez
Guillermo Garcia-Manero
Guillermo Montalban-Bravo
Kapil N Bhalla
Kiran Naqvi
Koichi Takahashi
Maria Khouri
P356
10.1002/AJH.25318
P407
P577
2018-11-15T00:00:00Z